Kevin Kane, CEO
Kevin started his statistical career in 1990 with Amgen. After 3 years, he moved to Wellcome and stayed in the GSK family of companies for a number of years. Having a variety of positions, including project statistician and technical support allowed him a broad oversight of the clinical trial process. Kevin set up PHASTAR in 2007, and is a Chartered Statistician and was a Board Member for PSI (Statisticians in the Pharmaceutical Industry). He is still actively involved in providing statistical support.
Andrew MacGarvey, Managing Director
Andrew began his career in statistical programming some twenty years ago and subsequently held various technical roles in contract research organisations. He has served on several boards and has worked in both the UK and the USA in leadership roles with a focus on growing businesses. Andrew is responsible for the operational delivery at PHASTAR as well the oversight of Quality Assurance, Finance, Administration, and Human Resources. He holds an MBA from the University of Newcastle and is currently completing a Law degree.
Joshua Baker, Head, US Biometrics
Josh has many years industry experience, developing and leading a number of biostatistics departments. He has extensive regulatory experience (IND, CTA, BLA, MAA, and post-licensing) in all geographies, including submission strategy and preparation; and has participated in multiple advisory committee meetings at the FDA for new therapeutics (small molecule and biologics). While heading up the US statistical division at Glaxo (GSK) he managed a team of 65 staff supporting over 40 development programs, with an average of 4-6 NDA/sNDA submissions per year. He has also introduced statistical services to multiple organizations and grown teams of up to 200 statisticians and programmers. Josh leads our US division based in North Carolina and is actively involved in providing statistical support.
Nadeem Elahi, Head, Customer and Business Strategy
Prior to joining PHASTAR, Nadeem had over 26 years' experience at GSK in a variety of analytical roles supporting drug development through to commercialisation. During his early career, he provided statistical consultancy to non-clinical and clinical projects across multiple therapeutic areas and phases of development. He then moved on to lead global strategic initiatives aimed at simplifying and streamlining the clinical development process. He has led statistical & programming departments in the US, UK and offshore locations to ensure high-quality delivery of a broad portfolio of projects. More recently, Nadeem was responsible for driving the GSK statistics and programming resourcing strategy globally, building strong partnerships with external functional service providers, while managing internal stakeholders. Nadeem is responsible for account strategy and management for some of our largest clients.
Sheelagh Aird, Head, Clinical Data Operations
Sheelagh started her data management career in 1990 where she worked as Assistant Director of Data Management, before setting up Exp-e-data in 2000. Sheelagh worked in Exp-e-data for 16 years, and then joined PHASTAR with PHASTAR's aquisition of Exp-e-data. Originally having a PhD in Pharmacokinetics, Sheelagh has experience of setting up and running clinical trials on a variety of data collection platforms.
Michelle Thomson, Statistics Manager
Michelle started working in the pharmaceutical industry in 1998, working in both pharmaceutical companies and CROs. Working as a statistician, she has experience primarily working in phase II-IV clinical trials across a wide range of therapeutic areas. She has experience in leading multiple projects on a global basis, as well as resource and line management. Michelle's particular area of interest is quality management, using her experience to contribute to continual process improvement within the company.
Andrew Lloyd, Statistics and Programming Manager
Andrew has over sixteen years of experience providing statistical consultancy support to project teams in the Pharmaceutical Industry. This has been across non-clinical research, early and late-phase clinical trials and for both small molecules and biopharmaceuticals. Working on multiple global projects simultaneously, he has provided proactive and expert leadership in the strategic application of statistical thinking to those teams and has been accountable for ensuring the timely delivery of quality statistical deliverables such as analysis plans and statistical reports. He has experience across multiple therapeutic areas including Oncology, Respiratory, Inflammation, and Neuroscience and is currently the joint-author of the literature review section of Pharmaceutical Statistical Journal.
Alison McLeod, Statistics Manager
Alison spent 25 years at Pfizer in Sandwich working on a variety of pre-clinical and clinical projects before joining PHASTAR as a statistical manager. Alison has strong organisational and analytical skills and currently leads large team of statisticians and programmers providing services to a large pharmaceutical company. Alison has a strong focus on ensuring the clients' needs are met, and also on ensuring staff development across the whole PHASTAR organisation.